volume 6, issue S10, PS1500-S1511 2017
DOI: 10.21037/tcr.2017.10.30
View full text
|
|
Share
Hannah Yejin Kim, Jennifer H. Martin, Andrew J. Mclachlan, Alan V. Boddy

Abstract: The prerequisites for the successful implementation of therapeutic drug monitoring (TDM) include high inter-subject variation, low inter-occasion variation, narrow therapeutic index and a strong link between plasma drug concentrations and clinical effects. The degree to which targeted anticancer drugs meet these criteria is not the only consideration in implementing precision dosing. Methodological, logistical, funding and cultural barriers also provide challenges to the successful implementation of approaches…

expand abstract